Preferred Networks to Launch “MN-1b” Private Sector Supercomputer Adopting NVIDIA Tesla V100 32GB GPUs
Preferred Networks, Inc. (PFN), a provider of IoT-centric deep learning systems, NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group, and NTT Com subsidiary NTT PC Communications Incorporated (NTT PC) announced today that PFN will launch an expanded version of its MN-1 private sector supercomputer equipped with NTT Com and NTTPC’s next-generation GPU platform by July. The new MN-1b supercomputer will adopt the NVIDIA® Tesla® V100 32GB, that was announced at GTC 2018 on March 27, 2018 (U.S. time).
PFN plans to enhance MN-1 by adding 512 NVIDIA Tesla V100 32GB GPUs and have them up and running by July, with the added GPUs having a theoretical peak performance of about 56 PetaFLOPS1, a massive 56,000 trillion floating-point operations per second, based on a mixed precision floating-point operation2 used in deep learning. This means the expansion alone will contribute to a roughly threefold increase from the current peak.
PFN expects the new supercomputer’s extra high speed and massive processing environment leveraging the latest GPUs will accelerate the real-world applications of its research and development in deep learning and related technologies and thereby strengthen PFN’s global competitiveness. NTT Com and NTT PC will build and operate the multi-node platform leveraging the latest GPUs that meets PFN’s requirements, using their knowledge of intra-GPU communication and waste heat processing.
"We are truly honored that Preferred Networks has chosen NVIDIA Tesla V100 32GB, most advanced data center GPU with 2X the memory, for its next-generation private supercomputer’s computation environment, “MN-1b”. With NTT Com Group’s experience of establishing and managing highly reliable data center services, combined with NVIDIA’s latest high-speed GPUs for deep learning, we sincerely look forward to R&D results in the fields of transportation systems, manufacturing and biotech/healthcare," said Masataka Osaki, Vice President of Corporate Sales and NVIDIA Japan Country Manager.
Emmy Chang, Board Director, Supermicro KK and VP of Strategic Sales, Supermicro said, “Preferred Networks is the first in the world to deploy our SuperServer® 4029GP-TRT2 equipped with the latest version of Intel® Xeon® Scalable processors and supporting eight NVIDIA Tesla V100 32GB GPU accelerators,” “Preferred Networks has developed the world-class private supercomputer through cooperative work with NTT Com Group, and Supermicro continues to support them with our latest innovative hardware and solutions. We are confident that Preferred Networks will achieve new heights with its new private supercomputer.”
PFN will use the new MN-1b to raise the speed of its ChainerTM open source deep-learning framework and further accelerate its research and development in fields that require a huge amount of computing resources, namely transportation systems, manufacturing, bio-healthcare, and creativity.
Going forward, NTT Com expects to increasingly support the delivery of AI technologies and related platforms for advanced research and commercialized deep learning, including the AI business initiatives of PFN.
1 A unit measuring computer performance. Peta is 1,000 trillion (10 to the power of 15) and FLOPS is used to count floating-point operations per second. So, 1 PetaFLOPS means that a computer is capable of performing 1,000 trillion floating-point calculations per second.
2 Mixed precision floating-point operation is a method of floating point arithmetic operations with combination of multiple precisions.
ChainerTM is a trademark or a registered trademark of Preferred Networks, Inc. in Japan and other countries. Other company names and product names written in this release are the trademarks or the registered trademarks of each company.
About Preferred Networks, Inc.
Founded in March 2014 with the aim of promoting business utilization of
deep learning technology focused on IoT, PFN advocates Edge Heavy
Computing as a way to handle the enormous amounts of data generated by
devices in a distributed and collaborative manner at the edge of the
network, driving innovation in three priority business areas:
transportation, manufacturing and bio/healthcare. PFN develops and
provides Chainer, an open source deep learning framework. PFN promotes
advanced initiatives by collaborating with world leading organizations,
such as Toyota Motor Corporation, Fanuc Corporation and the National
About NTT Communications Corporation
NTT Communications provides consultancy, architecture, security and
cloud services to optimize the information and communications technology
(ICT) environments of enterprises. These offerings are backed by the
company’s worldwide infrastructure, including the leading global tier-1
IP network, the Arcstar Universal One™ VPN network reaching over 190
countries/regions, and over 140 secure data centers worldwide. NTT
Communications’ solutions leverage the global resources of NTT Group
companies including Dimension Data, NTT DOCOMO and NTT DATA.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com | LinkedIn@NTT Com
NTT PC Communications Incorporated
NTTPC Communications Incorporated (NTTPC), established in 1985 is a subsidiary of NTT Communications, is a network service and communication solution provider in Japanese telco market, The company has been the most strategic technology company of the group throughout of years. NTTPC launched the 1st ISP service of the NTT group, so called “InfoSphere” at 1995, and also launched the 1st Internet Data Center and server hosting services of Japan so called “WebARENA” at 1997. NTTPC have always started something new in ICT market.
Ms. Yuko Miyamoto, Ms. Aoi Funagoshi, +81 3 6700 4010
Corporate Planning Department
NTT PC Communications Incorporated
Mr. Sato, Mr. Hayashi, +81 50 3388 1664
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting21.10.2018 01:30 | Tiedote
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent
Manchester United and True Religion Launch Denim Range19.10.2018 20:37 | Tiedote
Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion
Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10 | Tiedote
Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr
Tradeshift Announces Q3 2018 Results19.10.2018 14:00 | Tiedote
Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme